67
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting

, , , , &
Pages 1149-1157 | Published online: 19 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nakhleh E Abu-Yaghi, Alaa M Abed, Dana F Khlaifat, Mohammed B Nawaiseh, Laith O Emoush, Heba Z AlHajjaj, Ala M Abojaradeh, Mariana N Hattar, Sura K Abusaleem, Hashem M Sabbagh, Yazan A Abu Gharbieh & Sura A Quaqazeh. (2020) Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients. Clinical Ophthalmology 14, pages 921-929.
Read now

Articles from other publishers (4)

Daniele Veritti, Valentina Sarao, Valentina Soppelsa, Carla Danese, Jay Chhablani & Paolo Lanzetta. (2022) Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine 11:2, pages 325.
Crossref
Dae Hyun Park, Hae Jung Sun & Sung Jin Lee. (2016) A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration. International Ophthalmology 37:5, pages 1205-1214.
Crossref
João Pinheiro-Costa, José M. Costa, João N. Beato, Paulo Freitas-da-Costa, Elisete Brandão, Manuel S. Falcão, Fernando Falcão-Reis & Ângela M. Carneiro. (2015) Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice. Ophthalmologica 233:3-4, pages 155-161.
Crossref
João Pinheiro-Costa, Paulo Freitas-da-Costa, Manuel S. Falcão, Elisete M. Brandão, Fernando Falcão-Reis & Ângela M. Carneiro. (2014) Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison. Ophthalmologica 232:3, pages 149-155.
Crossref